Date published: 2025-11-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

N-Methyl-D-Aspartic acid (NMDA) (CAS 6384-92-5)

5.0(1)
Write a reviewAsk a question

See product citations (2)

Application:
N-Methyl-D-Aspartic acid (NMDA) is a definitiveionotropic NMDA receptor agonist
CAS Number:
6384-92-5
Purity:
≥98%
Molecular Weight:
147.1
Molecular Formula:
C5H9NO4
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

N-Methyl-D-Aspartic acid (NMDA) is a excitatory amino acid neurotransmitter predominantly present in the central nervous system (CNS). As a vital component of the glutamate-mediated excitatory neurotransmitter system, it plays a key role in facilitating long-term potentiation, an essential process for learning and memory formation. Its influence extends to various physiological processes encompassing neuroplasticity, neuronal development, and neuroprotection. N-Methyl-D-Aspartic acid (NMDA) acts through ligand-gated ion channels known as NMDA receptors, which are activated upon binding with N-Methyl-D-Aspartic acid (NMDA). Activation of these receptors allows the influx of calcium ions into the cell, leading to diverse physiological responses like neuronal excitation, synaptic plasticity, and long-term potentiation. N-Methyl-D-Aspartic acid (NMDA)′s impact spans several biochemical and physiological aspects, encompassing the regulation of neuronal excitability, synaptic plasticity, and long-term potentiation. It has also demonstrated involvement in neuronal development, synaptic plasticity, and long-term potentiation regulation. Furthermore, N-Methyl-D-Aspartic acid (NMDA) has exhibited various physiological effects such as anxiolytic, antidepressant, and anticonvulsant properties. N-Methyl-D-Aspartic acid (NMDA) itself can act as a synthetic agonist of the NMDA receptor, mimicking the binding action of the endogenous ligand glutamate. This receptor, a voltage-gated ion channel, is intricately involved in memory, spatial learning, and perturbing its normal behavior through N-Methyl-D-Aspartic acid (NMDA) exposure has aided in understanding NMDA receptor-mediated activities.


N-Methyl-D-Aspartic acid (NMDA) (CAS 6384-92-5) References

  1. Stimulation of NMDA and AMPA receptors in the rat nucleus basalis of Meynert affects sleep.  |  Manfridi, A., et al. 1999. Am J Physiol. 277: R1488-92. PMID: 10564223
  2. Occurrence of D-aspartic acid and N-methyl-D-aspartic acid in rat neuroendocrine tissues and their role in the modulation of luteinizing hormone and growth hormone release.  |  D'Aniello, A., et al. 2000. FASEB J. 14: 699-714. PMID: 10744627
  3. The role of D-aspartic acid and N-methyl-D-aspartic acid in the regulation of prolactin release.  |  D'Aniello, G., et al. 2000. Endocrinology. 141: 3862-70. PMID: 11014243
  4. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia.  |  Dracheva, S., et al. 2001. Am J Psychiatry. 158: 1400-10. PMID: 11532724
  5. Thyroid hormone regulation of N-methyl-D-aspartic acid receptor subunit mRNA expression in adult brain.  |  Lee, PR., et al. 2003. J Neuroendocrinol. 15: 87-92. PMID: 12535174
  6. Organization of single components of defensive behaviors within distinct columns of periaqueductal gray matter of the rat: role of N-methyl-D-aspartic acid glutamate receptors.  |  Bittencourt, AS., et al. 2004. Neuroscience. 125: 71-89. PMID: 15051147
  7. Model of infantile spasms induced by N-methyl-D-aspartic acid in prenatally impaired brain.  |  Velísek, L., et al. 2007. Ann Neurol. 61: 109-19. PMID: 17315208
  8. The induction and maintenance of central sensitization is dependent on N-methyl-D-aspartic acid receptor activation; implications for the treatment of post-injury pain hypersensitivity states.  |  Woolf, CJ. and Thompson, SWN. 1991. Pain. 44: 293-299. PMID: 1828878
  9. Structural, conformational, and stereochemical requirements of central excitatory amino acid receptors.  |  Hansen, JJ. and Krogsgaard-Larsen, P. 1990. Med Res Rev. 10: 55-94. PMID: 2153264
  10. Permeation and block of N-methyl-D-aspartic acid receptor channels by divalent cations in mouse cultured central neurones.  |  Mayer, ML. and Westbrook, GL. 1987. J Physiol. 394: 501-27. PMID: 2451020
  11. A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists.  |  Kessler, M., et al. 1989. J Neurochem. 52: 1319-28. PMID: 2538568
  12. The action of N-methyl-D-aspartic acid on mouse spinal neurones in culture.  |  Mayer, ML. and Westbrook, GL. 1985. J Physiol. 361: 65-90. PMID: 2580984
  13. N-methyl-D-aspartic acid-induced lethality in mice: selective antagonism by phencyclidine-like drugs.  |  Leander, JD., et al. 1988. Brain Res. 448: 115-20. PMID: 3292008
  14. Excitatory amino acid transmitters.  |  Watkins, JC. and Evans, RH. 1981. Annu Rev Pharmacol Toxicol. 21: 165-204. PMID: 6112965
  15. Testing the NMDA, long-term potentiation, and cholinergic hypotheses of spatial learning.  |  Cain, DP. 1998. Neurosci Biobehav Rev. 22: 181-93. PMID: 9579310

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

N-Methyl-D-Aspartic acid (NMDA), 50 mg

sc-200458
50 mg
$107.00

N-Methyl-D-Aspartic acid (NMDA), 250 mg

sc-200458A
250 mg
$362.00